James Roet

• Drive revenue growth across pharmaceutical, biotech, and academic institutions by aligning drug discovery workflows with immunoassay reagents and capital equipment solutions.
• Achieved President’s Club recognition and ranked #1 in North America for immunoassay portfolio performance.
• Consistently met or exceeded annual quota in a competitive, technically complex territory.
• Conduct virtual and on-site product demonstrations, scientific discussions, and workflow consultations to support customer evaluation and purchasing decisions.
• Engage scientific stakeholders including bench scientists, lab managers, and directors to understand experimental objectives and recommend appropriate solutions.
• Navigate sales processes involving technical validation, internal budgeting, and procurement review.
• Maintain territory forecasting, pipeline tracking, and account planning through Salesforce CRM.
• Partner cross-functionally with field application scientists, marketing, and product management to support customer success and market penetration.
• Provide market intelligence and customer feedback to internal teams to inform product positioning and development.

• Managed full sales cycle responsibilities across assigned territory.
• Developed strategic account relationships contributing to territory growth and increased product adoption.
• Supported customers in troubleshooting assay design, optimization, and workflow integration.

• Led development and commercialization of ELISA, multiplex bead-based assays, and chemiluminescent assays in FDA-regulated environments.
• Planned and executed assay development experiments; analyzed performance data using Softmax, GraphPad Prism, Minitab, and Excel.
• Led technology transfer and product launch activities for commercially available assays.
• Presented technical findings to senior leadership and cross-functional stakeholders.
• Served as technical liaison to prospective business partners.

• Developed SARS-CoV-2 antibody and antigen ELISA assays during COVID-19 pandemic.
• Designed and optimized assay reagents and protocols
• Designed and executed experiments and data for FDA Emergency Use Authorization submissions.

• Led development and commercialization of the company’s first product.
• Directed verification and validation studies supporting performance claims.
• Scaled manufacturing processes in regulated environments.
• Authored work instructions and supported quality control procedures.
• Collaborated on development of optical instrumentation for quantitative analyte detection.
• Provided technical support and onboarding for early customers.

• Led development of ELISA and lateral flow assays for clinical diagnostic applications.
• Validated equipment and processes in cGMP environment.

• Prepared viral and bacterial immunogens including upstream cell culture, viral propagation and microbial fermentation and downstream protein purification in regulated manufacturing setting.
• Contributed to process optimization and scale-up initiatives.

• Processed and purified IgG from hyperimmunized bovine colostrum for commercial animal health products.